Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

The study was retracted.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

IL-18 signaling helps mature Tregs move into the thymus.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Hair loss gene linked to prostate issues.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Certain gene mutations in Japanese people are linked to different types of hair loss, with some causing mild hair thinning and others leading to complete baldness.

IL-18 signaling helps mature Tregs move into the thymus.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

MCHR2 gene duplications may be linked to alopecia areata.

The MLPH gene is not linked to seasonal hair loss in Rhodesian Ridgeback dogs.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Gene variation affects prostate issues and hair loss.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

RXRα is crucial for proper immune response and links diet to immune function.

CD44 variant changes start alopecia areata, but don't maintain it.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Targeting CD200 could be a new treatment for rheumatoid arthritis.